For: | Zhang J, Tan SB, Guo ZG. CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes. World J Diabetes 2020; 11(6): 239-251 [PMID: 32547698 DOI: 10.4239/wjd.v11.i6.239] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v11/i6/239.htm |
Number | Citing Articles |
1 |
Kaiyven Afi Leslie, Sarah J. Richardson, Mark A. Russell, Noel G. Morgan. Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype. Diabetic Medicine 2021; 38(12) doi: 10.1111/dme.14724
|
2 |
Victoria C. Brom, Christof Burger, Dieter C. Wirtz, Frank A. Schildberg. The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.837645
|
3 |
Xi Su, Wenwen Jin, Lizhi Liu, Zifei Zhu, Cunyan Li. Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1256995
|
4 |
Shuang Yang, Ming Zhao, Sujie Jia. Macrophage: Key player in the pathogenesis of autoimmune diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1080310
|
5 |
Jeffrey S. Isenberg, Enrique Montero. Tolerating CD47. Clinical and Translational Medicine 2024; 14(2) doi: 10.1002/ctm2.1584
|
6 |
Henriette Reventlow Frederiksen, Alexandra Glantz, Kåre Kryger Vøls, Søren Skov, Pernille Tveden-Nyborg, Kristine Freude, Ulrik Doehn. CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice. Frontiers in Genome Editing 2024; 6 doi: 10.3389/fgeed.2024.1403395
|
7 |
David D. Roberts, Jeffrey S. Isenberg. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes. American Journal of Physiology-Cell Physiology 2021; 321(2): C201 doi: 10.1152/ajpcell.00175.2021
|
8 |
Robert C. Sharp, Matthew E. Brown, Melanie R. Shapiro, Amanda L. Posgai, Todd M. Brusko. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.739048
|